Asia Pacific Artificial Intelligence In Precision Medicine Market Size & Outlook
The artificial intelligence in precision medicine market in Asia Pacific is expected to reach a projected revenue of US$ 7,102.0 million by 2033. A compound annual growth rate of 40.9% is expected of Asia Pacific artificial intelligence in precision medicine market from 2026 to 2033.
Healthcare IT
AI in Healthcare
artificial intelligence precision medicine market report
Asia Pacific artificial intelligence in precision medicine market highlights
The Asia Pacific artificial intelligence in precision medicine market generated a revenue of USD 455.1 million in 2025.
The market is expected to grow at a CAGR of 40.9% from 2026 to 2033.
In terms of segment, deep learning was the largest revenue generating technology in 2025.
Natural language processing is the most lucrative technology segment registering the fastest growth during the forecast period.
Country-wise, Japan is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
Market revenue in 2025
USD 455.1 million
Market revenue in 2033
USD 7,102.0 million
Growth rate
40.9% (CAGR from 2026 to 2033)
Largest segment
Deep learning
Fastest growing segment
Natural language processing
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Deep Learning, Querying Method, Natural language processing, Context aware processing
Key market players worldwide
BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic
Other key industry trends
In terms of revenue, Asia Pacific region accounted for 18.8% of the global artificial intelligence in precision medicine market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 7,102.0 million by 2033.
Some Asian countries have also started their national genomics initiatives, establishing their population genetic databases by sequencing the DNA of healthy people. For instance, Thailand recently authorized the USD 150 million 5-year Genomics Thailand Initiative to characterize the genomes of 50,000 citizens.
Singapore has a national precision medicine strategy that includes genetic material of 10,000 ethnically diverse, healthy people of Singapore. The second phase of the strategy is to increase the data bank to 100,000 healthy persons and increase the application of precision medicine in clinical practice.
In June 2020, Infosys, a pioneer in next-generation digital services and consulting, announced the launch of personalized medicine solution for the pharmaceutical sector. With the solution, pharmaceutical companies would handle business and regulatory needs while providing patients.
Asia Pacific artificial intelligence precision medicine market report
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Artificial Intelligence In Precision Medicine Market Outlook will help companies and investors design strategic landscapes.
Deep Learning was the largest segment with a revenue share of 47.44% in 2025.
Horizon Databook has segmented the Asia Pacific artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2021 to 2033.
Some Asian countries have also started their national genomics initiatives, establishing their population genetic databases by sequencing the DNA of healthy people. For instance, Thailand recently authorized the USD 150 million 5-year Genomics Thailand Initiative to characterize the genomes of 50,000 citizens.
Singapore has a national precision medicine strategy that includes genetic material of 10,000 ethnically diverse, healthy people of Singapore. The second phase of the strategy is to increase the data bank to 100,000 healthy persons and increase the application of precision medicine in clinical practice.
In June 2020, Infosys, a pioneer in next-generation digital services and consulting, announced the launch of personalized medicine solution for the pharmaceutical sector. With the solution, pharmaceutical companies would handle business and regulatory needs while providing patients.
Asia Pacific Artificial Intelligence In Precision Medicine Market Technology Outlook (Revenue, USD Million , 2021-2033)
Deep Learning
Querying Method
Natural language processing
Context aware processing
Asia Pacific Artificial Intelligence In Precision Medicine Market Component Outlook (Revenue, USD Million , 2021-2033)
Hardware
Software
Service
Asia Pacific Artificial Intelligence In Precision Medicine Market Therapeutic Application Outlook (Revenue, USD Million , 2021-2033)
Oncology
Cardiology
Neurology
Respiratory
Others
Reasons to subscribe to artificial intelligence precision medicine market report databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of artificial intelligence precision medicine market report databook
Our clientele includes a mix of artificial intelligence precision medicine market report companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific artificial intelligence precision medicine market report, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific artificial intelligence precision medicine market report from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Artificial Intelligence In Precision Medicine Market, 2021-2033 (US$M)